Manulife (Manufacturers Life Insurance)
ATOS icon

Manulife (Manufacturers Life Insurance)’s Atossa Therapeutics ATOS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,268
Closed -$12.8K – 2910
2025
Q1 		$12.8K Sell
1,268
-1,821
-59% -$22.1K ﹤0.01% 2889
2024
Q4 		$43.7K Sell
3,089
-185
-6% -$3.61K ﹤0.01% 2942
2024
Q3 		$74.7K Buy
+3,274
New +$66.1K ﹤0.01% 2934
2022
Q2 		– Sell
-3,443
Closed -$64.6K – 3016
2022
Q1 		$64.6K Sell
3,443
-936
-21% -$19K ﹤0.01% 3019
2021
Q4 		$105 Buy
4,379
+69
+2% +$2.52K ﹤0.01% 3045
2021
Q3 		$211K Sell
4,310
-215
-5% -$12.5K ﹤0.01% 2944
2021
Q2 		$429K Buy
+4,525
New +$240K ﹤0.01% 2550

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ATOS Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Atossa Therapeutics (ATOS) in Q2 2025, closing a stake of 1,268 shares — an estimated $12.8K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ATOS in Q2 2021 and held it in 7 quarters. The position peaked at $429K in Q2 2021. 84 funds tracked by Wall St. Rank hold ATOS as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Atossa Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,268 Atossa Therapeutics shares in Q2 2025, an estimated $12.8K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Atossa Therapeutics in Q2 2021 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s Atossa Therapeutics position peaked at $429K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.